<collection><source>PMC</source><date>20230508</date><key>pmc.key</key><document><id>31339</id><infon key="license">NO-CC CODE</infon><passage><infon key="article-id_doi">10.1186/1471-213X-1-5</infon><infon key="article-id_pmc">31339</infon><infon key="article-id_pmid">11305929</infon><infon key="article-id_publisher-id">1471-213X-1-5</infon><infon key="fpage">5</infon><infon key="journal-title">BMC Developmental Biology</infon><infon key="lpage">5</infon><infon key="name_0">surname:Jaskoll;given-names:Tina</infon><infon key="name_1">surname:Chen;given-names:Haiming</infon><infon key="name_2">surname:Min Zhou;given-names:Yan</infon><infon key="name_3">surname:Wu;given-names:Dingwen</infon><infon key="name_4">surname:Melnick;given-names:Michael</infon><infon key="section_type">TITLE</infon><infon key="type">front</infon><infon key="volume">1</infon><infon key="year">2001</infon><offset>0</offset><text>Developmental expression of survivin during embryonic submandibular salivary gland development</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>95</offset><text>What is the background on this?</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>106</offset><text>Survivin, an IAP family member that is expressed in embryonic cells, plays a crucial role in regulating programmed cell death and maintaining developmental homeostasis. As such, it is both an anti-apoptosic factor and burgeoning factor in survival rates.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>618</offset><text>What are the outcomes?</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>626</offset><text>We examined the developmental expression of survivin in Pseudoglandular ( E14), Canalicular (p.c.), and Terminal Bud (pp. e17) Stage SMGs and found that transcript levels increased by 26% between the Canalism and terminal Bud Stages. Immunohistochemical studies revealed that nuclear-localized survis protein was expressed in epithelial cells bounding lumina in the Arthritis lab.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>1038</offset><text>Remarkable conclusions</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>1050</offset><text>Our study demonstrates that survivin may play a crucial role in the survival of embryonic SMG epithelial cells, as it is known to promote survival through its pro-survival and anti-apoptotic properties. Furthermore, survisin protein localization into the nucleus is essential for cell cycle entry and preventing cellular death.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>1460</offset><text>Introduction</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>1473</offset><text>The submandibular gland is a small, elongated gland located behind the right ear. It is responsible for the production of salivary glands for the mouth. This gland is located in the submandibular region of the salivary gland.

The submandibular gland produces salivary glands in response to specific stimuli. These salivary glands secrete a secretion called salivary gland secretions that are secreted into the submandibular gland. The secretion is produced by the submandibular gland in response to the presence of external stimuli, such as a stimulus that triggers the secretion of salivary gland secretions.

Salivary gland secretions are secreted in response to stimulation of the salivary gland; for example, by a stimulation that activates</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>2852</offset><text>Survivin, an IAP family protein that regulates programmed cell death, is highly expressed in embryonic tissues, cancer cells, and is undetectable in normal adult tissues. It has been shown that survivon is essential for development and has also been important for mitosis as it can prevent microvaginal degeneration.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>3927</offset><text>We hypothesized that survivin plays a crucial role as 'pro-survival and anti-apoptotic' molecule during embryonic ductal (and proacinar) formation"; in this paper we report the first observation of developmental changes in survisin expression and protein localization associated with embryonal lumen formation, expressed as transcripts and proteins from embryoNIC SMGs.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_1</infon><offset>4342</offset><text>Results and Discussion</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>4365</offset><text>Expression of Survivin Transcript</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>4399</offset><text>To elucidate a potential role for survivin during embryonic SMG morphogenesis, we evaluated survivin transcript levels in Pseudoglandular (~ E14), Canalicular (~ E15) and Terminal Bud (~ E17) Stage SMGs using primer extension analysis. As shown in Figure 1, survivin transcripts were detected in all stages investigated. There was no significant change in survivin mRNA levels between the Pseudoglandular and Canalicular Stages. By contrast, there was a significant ~ 26% increase (p &lt; 0.05) in survivin transcript levels between the Canalicular and Terminal Bud Stages, this significant increase being concomitant with extensive epithelial cell apoptosis which results in lumina formation.</text></passage><passage><infon key="file">1471-213X-1-5-1.jpg</infon><infon key="id">F1</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>5090</offset><text>Quantitative analysis of survivin trancript levels during embryonic SMG development. Inset. Primer extension analysis of Pseudoglandular (Ps), Canalicular (Ca) and Terminal Bud (TB) Stage SMGs. The relative level of survivin transcript is presented as the percent transcript level relative to that in Pseudoglandular Stage SMGs.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>5419</offset><text>Determination of Antibody Specificity</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>5457</offset><text>Prior to determining the cell-specific distribution of survivin protein during embryonic SMG development, the specificity of the anti-survivin antibody was evaluated by determining its reactivity on Western blots of lysates of 3 cancer cell lines (MO7E, HL-60, and HELA) since cancer cell lines have been shown to overexpress survivin protein [ ]. Using the unpurified anti-survivin antiserum, survivin protein (Mr ~ 16 kDa) was detected in all cell lines but not in normal whole human blood cell lysates (Fig. 2); survivin was not detected by the control serum. After affinity purification, a single ~ 16 kDa band was detected in HL-60 human cells (Fig. 3) using this antibody; no band was seen in the affinity column eluate of the preimmune serum. Our affinity-purified antibody was then evaluated for its ability to localize survivin protein in tissue sections. Our observation of survivin immunolocalization in pulmonary epithelia (data not shown) is identical to that previously reported. Based on the above results, we conclude that this anti-survivin antibody is specific for survivin protein.</text></passage><passage><infon key="file">1471-213X-1-5-2.jpg</infon><infon key="id">F2</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>6558</offset><text>Western blot analysis using whole antiserum shows the presence of survivin protein in 3 cancer cell lines (MO7E, HL-60, and HELA). Survivin protein was not detected in whole blood lysates or control preimmune serum.</text></passage><passage><infon key="file">1471-213X-1-5-3.jpg</infon><infon key="id">F3</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>6774</offset><text>Western blot analysis for survivin expression. Using affinity-purified anti-survivin antibody, survivin protein was identified as a single ~ 16 kDa band in HL-60 lysates. No band was seen in affinity column eluate of prebleed serum.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>7007</offset><text>Spatiotemporal Distribution of Survivin</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>7047</offset><text>We then evaluated the pattern of survivin immunolocalization in embryonic SMGs with progressive development. In the Pseudoglandular Stage, survivin protein is diffusely distributed throughout the cytoplasm of branching epithelia and is absent from the mesenchyme (Fig. 4A). This cytoplasmic distribution of survivin protein suggests that survivin may not have translocated into the nucleus to form a survivin/Cdk4 complex at this early developmental stage. In the Canalicular Stage, epithelial cell apoptosis toward the center of presumptive ducts results in initial ductal lumen formation. At the sites of lumen formation, intense survivin staining is seen in nuclei of the columnar epithelial cells bounding forming lumina (Fig. 4B). In contrast, those epithelial cells not surrounding the forming lumen do not display nuclear-localized survivin protein (Fig. 4B). As development progresses through the Terminal Bud Stage, terminal buds hollow out until only a single layer of epithelial cells surround terminal bud lumina (Fig. 4C). Nuclear-localized survivin protein is seen in these lumen-bounding terminal bud epithelial cells destined to survive (Fig. 4D), as well as in lumen-bounding ductal epithelia (Fig. 4E). Although nuclear translocation of survivin has been shown to be required for survivin-induced initiation of the cell cycle in cell lines in vitro, this is the first report of survivin translocation into the nuclei of embryonic cells in vivo. Cell proliferation, but not apoptosis, is seen in this single layer of terminal bud epithelial cells which is adjacent to mesenchyme and extracellular matrix. This observation is consistent with the previous report that survivin is primarily found in proliferating cells.</text></passage><passage><infon key="file">1471-213X-1-5-4.jpg</infon><infon key="id">F4</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>8782</offset><text>Spatial distribution of survivin protein during embryonic SMG development. A. Survivin protein is diffusely distributed throughout the branching epithelia (e) and absent from the mesenchyme (m) in the Pseudoglandular Stage. B. Intense survivin immunostain is seen in ductal columnar epithelial cells which surround forming lumina (arrow heads) in the Canalicular Stage. By contrast, survivin protein retains its diffuse distribution in terminal bud (t) epithelia lacking lumina and in outer ductal cuboidal epithelial cells. C-E. Terminal Bud Stage SMGs exhibit distinct lumina in presumptive ducts (d) and acini (a). Note intense immunostain in the inner layer of ductal epithelia and the single layer of terminal bud epithelia which surround distinct lumina . D. Higher magnification of Terminal Bud Stage SMG exhibiting nuclear localization (arrows) of survivin protein in presumptive acini cells bounding distinct lumina (*). E. Higher magnification of a Late Terminal Bud Stage ductal epithelial bilayer which consists of an inner columnar epithelia which surround the distinct lumen and an outer cuboidal epithelia which abuts the basement membrane. Nuclear localization (double arrowheads) of survivin protein is seen in the inner layer of columnar epithelial cells surrounding the lumen (*) and not in the outer cuboidal epithelia. A-C. Bar, 50 &#956;m. D-E, Bar, 25 &#956;m.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>10158</offset><text>Although survivin has previously been demonstrated in embryonic lung epithelia, this is the first report of qualitative and quantitative changes in survivin expression in any developing branching organ. Further, it is interesting to note that substantial differences in survivin protein localization exist between embryonic lungs and SMGs. Survivin protein is nuclear-localized in late embryonic SMG epithelia surrounding forming lumina (Fig. 4) whereas it remains diffusely distributed, and not nuclear-localized, in pulmonary lumen-bounding epithelia (data not shown). The likely explanation for this notable difference in these analogous branching organs is the different mechanisms of their lumina formation. The pulmonary lumen forms as an extension of the tracheal lumen into the lung bud; repeated branching of the lung bud results in an extensive epithelial tree which surrounds the pulmonary lumina. Since apoptosis is not a key factor in pulmonary lumina formation, a pro-survival/anti-apoptosis signal is not needed for epithelial cell survival and, thus, the survivin pathway is not activated. By contrast, the SMG bud develops as a solid cord of epithelium, with SMG lumina being formed by the death of central epithelial cells, and subsequently each consecutive concentric layer of terminal bud epithelial cells, until a single layer of "surviving" epithelial cells surround the lumina. Thus, molecule(s) mediating an apoptotic stop signal are required for these lumen-bounding epithelial cells to survive. Interestingly, Bcl-2 and NF&#954;B, other pro-survival/anti-apoptosis factors, are absent from these Terminal Bud stage bud epithelia. Given that survivin translocation into the nucleus is necessary for Cdk4/survivin complex formation, induction of cell cycle entry, and inhibition of caspase 3-mediated apoptosis, our observation of nuclear-localized survivin protein in proacinar (Fig. 4D) and ductal epithelia (Fig. 4E) suggests that survivin may be a key factor for the survival of epithelial cells surrounding forming ductal and terminal bud lumina.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>12233</offset><text>Finally, it is interesting that extensive cell proliferation, but not apoptosis, is seen in Initial Bud and Pseudoglandular Stage SMG epithelia in the absence of survivin protein. To gain insight into which molecules likely protect these early embryonic SMG cells from apoptosis, we must turn to recent gene targeting experiments investigating FGF-10 and its receptor, FGF-R2(IIIb). Analysis of Fgf10 null and Fgfr2(IIIb) transgenic mice indicate that FGF10/FGF-R2(IIIb) signal transduction is essential for SMG branching morphogenesis; SMGs are absent in E14.5 and older mice. However the presence of an initial SMG epithelial bud which subsequently undergoes cell death in the absence of FGF-R2(IIIb) signaling, suggests that FGF10/FGF-R2-(IIIb) signaling mediates epithelial cell survival during the Pseudoglandular Stage. What remains unclear is which factor or factors protect the initial bud epithelium from apoptosis. Further studies are needed to address this question.</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">title_1</infon><offset>13211</offset><text>Remarkable conclusions</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">paragraph</infon><offset>13223</offset><text>The role of apoptosis in the formation of embryonic SMG ductal and proacinar lumens is well-known, but there is limited information on which factor(s) mediate the anti-appetitosity/pro-survival signal. Not only did survivin protein increase during SMF lumina formation, however, it was hypothesized that it may be largely responsible for survival of epithelial cells.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_1</infon><offset>13722</offset><text>Materials and Methods</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>13744</offset><text>Tissue Collection</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>13762</offset><text>Female B10A/SnSg mice, obtained from Jackson Laboratories (Bar Harbor, ME), were maintained and mated as previously described; plug day = day 0 of gestation. Pregnant females were anesthetized on days 14-18 of gestation (E14-18) with methoxyflurane (metafane) and euthanized by cervical dislocation. This research conformed to the Animal Resource Institutional Review and Ethics Committee. Embryos were dissected in cold phosphate buffered saline (PBS) and staged according to Theiler. E14-E18 SMGs and E15-E17 lungs were collected and stored at -70&#176;C or processed for histology.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>14343</offset><text>Analysis of RNA by Primer Extension</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>14379</offset><text>Total RNA from E14 Pseudoglandular SMGs (64 glands/3 litters); E15 Canalicular SMGs (52 glands/3 litters) and E17 Terminal Bud SMGs (48 glands/3 litters) were extracted as previously described. Primer extension was conducted essentially as described in Li and Altieri. A msg-PE oligonucleotide 5'-GGCTCTTTCTCTGCT CAGTTT-3' was synthesized, gel purified and 5' end-labeled; a control primer was also radiolabled. For primer extension, 40 &#956;g total RNA per stage was hybridized with an excess of 5'-radiolabeled DNA primers. The resulting end-labeled cDNA was separated on a urea-denaturing polyacrylamide gel, visualized, and quantitated by phosphor image analysis with ImageQuant software. Relative levels of survivin mRNA were tabulated as the percent transcript level relative to that in the Pseudoglandular Stage. Subsequent analysis was by t-test for the significance of differences between percentages based on the arcsin transformation; it employs a constant representing the parametric variance of a distribution of arcsin transformations of percentages.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>15441</offset><text>Immunohistochemistry</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>15462</offset><text>A rabbit polyclonal antibody was raised against a 19 aa peptide [NH2-MGAPTLPPAW OPFLKDHRI-COOH] representing amino acids 1-19 of the deduced human amino acid sequence. Using anti-survivin antiserum and Western blot analysis, survivin protein (Mr ~ 16 kDa) was detected in the lysates of 3 cancer cell lines (MO7E, HL-60, and HELA), but not in normal whole human blood cell lysates; survivin was not detected by the control serum. The antibody was purified from the immune sera by affinity chromatography on a peptide column and specificity determined by Western blot analysis. Extracts of the HL-60 were analyzed to demonstrate antibody specificity. No band was seen in control affinity column eluate of the prebleed serum. For immunolocalization studies, embryonic SMGs and lungs were fixed in Carnoy's fixative, processed, and immunohistochemistry conducted as previously described. Immunohistochemical staining was performed using the Elite ABC kit (Vector Laboratories, Burlingham, CA).</text></passage><passage><infon key="fpage">252</infon><infon key="lpage">268</infon><infon key="name_0">surname:Jaskoll;given-names:T</infon><infon key="name_1">surname:Melnick;given-names:M</infon><infon key="pub-id_doi">10.1002/(SICI)1097-0185(19991101)256:3&lt;252::AID-AR5&gt;3.0.CO;2-6</infon><infon key="pub-id_pmid">10521784</infon><infon key="section_type">REF</infon><infon key="source">Anat Rec</infon><infon key="type">ref</infon><infon key="volume">256</infon><infon key="year">1999</infon><offset>16453</offset><text>Submandibular gland morphogenesis: stage-specific expression of TGF-&#945;/EGF, IGF, TGF-&#946;, TNF, and IL-6 signal transduction in normal embryonic mice and the phenotypic effects of TF-&#946;2, TGF-&#946;3 and EGF-R null mutations.</text></passage><passage><infon key="fpage">199</infon><infon key="lpage">215</infon><infon key="name_0">surname:Melnick;given-names:M</infon><infon key="name_1">surname:Jaskoll;given-names:T</infon><infon key="pub-id_pmid">12002815</infon><infon key="section_type">REF</infon><infon key="source">Crit Rev Oral Biol Med</infon><infon key="type">ref</infon><infon key="volume">11</infon><infon key="year">2000</infon><offset>16682</offset><text>Mouse submandibular gland morphogenesis: a paradigm for embryonic signal processing.</text></passage><passage><infon key="fpage">318</infon><infon key="lpage">330</infon><infon key="name_0">surname:Melnick;given-names:M</infon><infon key="name_1">surname:Chen;given-names:H</infon><infon key="name_2">surname:Zhou;given-names:Y</infon><infon key="name_3">surname:Jaskoll;given-names:T</infon><infon key="pub-id_doi">10.1002/1097-0185(20010301)262:3&lt;318::AID-AR1023&gt;3.0.CO;2-3</infon><infon key="pub-id_pmid">11241200</infon><infon key="section_type">REF</infon><infon key="source">Anat Rec</infon><infon key="type">ref</infon><infon key="volume">262</infon><infon key="year">2001</infon><offset>16767</offset><text>Embryonic mouse submandibular gland morphogenesis and the TNF/TNF-R1 signal transduction pathway.</text></passage><passage><infon key="fpage">43</infon><infon key="lpage">49</infon><infon key="name_0">surname:Adida;given-names:C</infon><infon key="name_1">surname:Crotty;given-names:PL</infon><infon key="name_2">surname:McGrath;given-names:J</infon><infon key="name_3">surname:Berrebi;given-names:D</infon><infon key="name_4">surname:Altieri;given-names:DC</infon><infon key="pub-id_pmid">9422522</infon><infon key="section_type">REF</infon><infon key="source">Am J Path</infon><infon key="type">ref</infon><infon key="volume">152</infon><infon key="year">1998</infon><offset>16865</offset><text>Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation.</text></passage><passage><infon key="fpage">1327</infon><infon key="lpage">1333</infon><infon key="name_0">surname:Altieri;given-names:DC</infon><infon key="name_1">surname:Marchisio;given-names:C</infon><infon key="pub-id_pmid">10576203</infon><infon key="section_type">REF</infon><infon key="source">Lab Inv</infon><infon key="type">ref</infon><infon key="volume">79</infon><infon key="year">1999</infon><offset>16987</offset><text>Survivin Apoptosis: an interloper between cell death and cell proliferation in cancer.</text></passage><passage><infon key="fpage">917</infon><infon key="lpage">921</infon><infon key="name_0">surname:Ambrosini;given-names:G</infon><infon key="name_1">surname:Adida;given-names:C</infon><infon key="name_2">surname:Altieri;given-names:DC</infon><infon key="pub-id_pmid">9256286</infon><infon key="section_type">REF</infon><infon key="source">Nat Med</infon><infon key="type">ref</infon><infon key="volume">3</infon><infon key="year">1997</infon><offset>17074</offset><text>A novel antiapoptosis gene, survivin, expressed in cancer and lymphoma.</text></passage><passage><infon key="fpage">1457</infon><infon key="lpage">1462</infon><infon key="name_0">surname:Kobayashi;given-names:K</infon><infon key="name_1">surname:Hatano;given-names:M</infon><infon key="name_2">surname:Otaki;given-names:M</infon><infon key="name_3">surname:Ogasawara;given-names:T</infon><infon key="name_4">surname:Tokushisa;given-names:T</infon><infon key="pub-id_doi">10.1073/pnas.96.4.1457</infon><infon key="pub-id_pmid">9990045</infon><infon key="section_type">REF</infon><infon key="source">Proc Natl Acad Sci USA</infon><infon key="type">ref</infon><infon key="volume">96</infon><infon key="year">1999</infon><offset>17146</offset><text>Expression of a murine homologue of the inhibitor of apoptosis protein is related to cell proliferation.</text></passage><passage><infon key="fpage">11177</infon><infon key="lpage">11182</infon><infon key="name_0">surname:Ambrosini;given-names:G</infon><infon key="name_1">surname:Adida;given-names:C</infon><infon key="name_2">surname:Siruga;given-names:G</infon><infon key="name_3">surname:Altieri;given-names:DC</infon><infon key="pub-id_doi">10.1074/jbc.273.18.11177</infon><infon key="pub-id_pmid">9556606</infon><infon key="section_type">REF</infon><infon key="source">J Biol Chem</infon><infon key="type">ref</infon><infon key="volume">273</infon><infon key="year">1998</infon><offset>17251</offset><text>Induction of apoptosis of inhibition by survivin gene targeting.</text></passage><passage><infon key="fpage">1319</infon><infon key="lpage">1328</infon><infon key="name_0">surname:Uren;given-names:AG</infon><infon key="name_1">surname:Wong;given-names:L</infon><infon key="name_2">surname:Pakusch;given-names:M</infon><infon key="name_3">surname:Fowler;given-names:KJ</infon><infon key="name_4">surname:Burrows;given-names:FJ</infon><infon key="name_5">surname:Vaux;given-names:DL</infon><infon key="name_6">surname:Choo;given-names:KHA</infon><infon key="pub-id_doi">10.1016/S0960-9822(00)00769-7</infon><infon key="pub-id_pmid">11084331</infon><infon key="section_type">REF</infon><infon key="source">Current Biology</infon><infon key="type">ref</infon><infon key="volume">10</infon><infon key="year">2000</infon><offset>17316</offset><text>Survivin and the inner centromere protein INCENP show similar cell cycle localization and gene knockout phenotype.</text></passage><passage><infon key="fpage">3143</infon><infon key="lpage">3151</infon><infon key="name_0">surname:Li;given-names:F</infon><infon key="name_1">surname:Altieri;given-names:DC</infon><infon key="pub-id_pmid">10397257</infon><infon key="section_type">REF</infon><infon key="source">Canc Res</infon><infon key="type">ref</infon><infon key="volume">59</infon><infon key="year">1999</infon><offset>17431</offset><text>The cancer antiapoptosis mouse survivin gene: characterization of locus and transcriptional requirements of basal and cell cycle-dependent expression.</text></passage><passage><infon key="fpage">3225</infon><infon key="lpage">3234</infon><infon key="name_0">surname:Suzuki;given-names:A</infon><infon key="name_1">surname:Hayashida;given-names:M</infon><infon key="name_2">surname:Ito;given-names:T</infon><infon key="name_3">surname:Kawano;given-names:H</infon><infon key="name_4">surname:Nakano;given-names:T</infon><infon key="name_5">surname:Miura;given-names:M</infon><infon key="name_6">surname:Akahane;given-names:K</infon><infon key="name_7">surname:Shiraki;given-names:K</infon><infon key="pub-id_doi">10.1038/sj/onc/1203665</infon><infon key="pub-id_pmid">10918579</infon><infon key="section_type">REF</infon><infon key="source">Oncogene</infon><infon key="type">ref</infon><infon key="volume">19</infon><infon key="year">2000</infon><offset>17582</offset><text>Survivin initiates cell cycle entry by the competitive interaction with Cdk4/p16(INK4a) and Cdk2/Cyclin E complex activation.</text></passage><passage><infon key="fpage">1346</infon><infon key="lpage">1353</infon><infon key="name_0">surname:Suzuki;given-names:A</infon><infon key="name_1">surname:Ito;given-names:T</infon><infon key="name_2">surname:Kawano;given-names:H</infon><infon key="name_3">surname:Hayashida;given-names:M</infon><infon key="name_4">surname:Hayasaki;given-names:Y</infon><infon key="name_5">surname:Tsutomi;given-names:Y</infon><infon key="name_6">surname:Akahane;given-names:K</infon><infon key="name_7">surname:Nakano;given-names:T</infon><infon key="name_8">surname:Miura;given-names:M</infon><infon key="name_9">surname:Shiraki;given-names:K</infon><infon key="pub-id_doi">10.1038/sj/onc/1203429</infon><infon key="pub-id_pmid">10713676</infon><infon key="section_type">REF</infon><infon key="source">Oncogene</infon><infon key="type">ref</infon><infon key="volume">19</infon><infon key="year">2000</infon><offset>17708</offset><text>Survivin initiates procase3/p21 complex formation as a result of ineraction with Ckd4 to resist Fas-mediated cell death.</text></passage><passage><infon key="fpage">111</infon><infon key="lpage">130</infon><infon key="name_0">surname:Ten;given-names:Have-Opbroek</infon><infon key="pub-id_pmid">2050021</infon><infon key="section_type">REF</infon><infon key="source">Exp Lung Res</infon><infon key="type">ref</infon><infon key="volume">17</infon><infon key="year">1991</infon><offset>17829</offset><text>Lung development in mouse embryos.</text></passage><passage><infon key="name_0">surname:Melnick;given-names:M</infon><infon key="name_1">surname:Chen;given-names:H</infon><infon key="name_2">surname:Zhou;given-names:Y</infon><infon key="name_3">surname:Jaskoll;given-names:T</infon><infon key="pub-id_pmid">11275690</infon><infon key="section_type">REF</infon><infon key="source">Cells, Tissues, Organs</infon><infon key="type">ref</infon><infon key="year">2001</infon><offset>17864</offset><text>Interleukin-6 signaling and embryonic mouse submandibular salivary gland morphogenesis.</text></passage><passage><infon key="fpage">1080</infon><infon key="lpage">1085</infon><infon key="name_0">surname:Ito;given-names:T</infon><infon key="name_1">surname:Shiraki;given-names:K</infon><infon key="name_10">surname:Nakano;given-names:T</infon><infon key="name_11">surname:Suzuki;given-names:A</infon><infon key="name_2">surname:Sugimoto;given-names:K</infon><infon key="name_3">surname:Yamanaka;given-names:T</infon><infon key="name_4">surname:Fujikawa;given-names:K</infon><infon key="name_5">surname:Ito;given-names:M</infon><infon key="name_6">surname:Takase;given-names:K</infon><infon key="name_7">surname:Moriyama;given-names:M</infon><infon key="name_8">surname:Kawamo;given-names:H</infon><infon key="name_9">surname:Hayashida;given-names:M</infon><infon key="pub-id_pmid">10796883</infon><infon key="section_type">REF</infon><infon key="source">Hepatology</infon><infon key="type">ref</infon><infon key="volume">31</infon><infon key="year">2000</infon><offset>17952</offset><text>Survivin promotes cell proliferation in human hepatocellular carcinoma.</text></passage><passage><infon key="fpage">483</infon><infon key="lpage">492</infon><infon key="name_0">surname:De Moerlooze;given-names:L</infon><infon key="name_1">surname:Spencer-Dene;given-names:B</infon><infon key="name_2">surname:Revest;given-names:J-M</infon><infon key="name_3">surname:Hajihosseini;given-names:M</infon><infon key="name_4">surname:Rosewell;given-names:I</infon><infon key="name_5">surname:Dickson;given-names:C</infon><infon key="pub-id_pmid">10631169</infon><infon key="section_type">REF</infon><infon key="source">Development</infon><infon key="type">ref</infon><infon key="volume">127</infon><infon key="year">2000</infon><offset>18024</offset><text>An important role for the IIIb isoform of fibroblast growth factor receptor 2 (FGFR2) in mesenchymal-epithelial signaling during mouse organogenesis.</text></passage><passage><infon key="fpage">643</infon><infon key="lpage">649</infon><infon key="name_0">surname:Oheyo;given-names:O</infon><infon key="name_1">surname:Hori;given-names:Y</infon><infon key="name_2">surname:Yamasaki;given-names:M</infon><infon key="name_3">surname:Harada;given-names:H</infon><infon key="name_4">surname:Sekine;given-names:K</infon><infon key="name_5">surname:Kato;given-names:S</infon><infon key="name_6">surname:Itoh;given-names:N</infon><infon key="pub-id_doi">10.1006/bbrc.2000.3721</infon><infon key="section_type">REF</infon><infon key="source">Bioch Bioph Res Comm</infon><infon key="type">ref</infon><infon key="volume">277</infon><infon key="year">2000</infon><offset>18174</offset><text>FGF10 acts as a major ligand for FGF Receptor 2 IIIb in mouse multiorgan development.</text></passage><passage><infon key="name_0">surname:Theiler;given-names:K</infon><infon key="section_type">REF</infon><infon key="source">Springer-Verlag, New York</infon><infon key="type">ref</infon><infon key="year">1989</infon><offset>18260</offset><text>The House Mouse.</text></passage><passage><infon key="fpage">607</infon><infon key="lpage">608</infon><infon key="name_0">surname:Sokal;given-names:RR</infon><infon key="name_1">surname:Rohlf;given-names:FJ</infon><infon key="section_type">REF</infon><infon key="source">San Francisco: W H Freeman,</infon><infon key="type">ref</infon><infon key="year">1969</infon><offset>18277</offset><text>Biometry.</text></passage></document></collection>